Together, our findings suggest that ICAM-1-suPAR-CD11b axis promotes TNBC metastasis via enhancing tumor cell and neutrophil binding, which provides a strong rationale for targeting this axis to block TNBC metastasis. This evidence concerns the gene ITGAM and neoplasm.